Anubis Barcelona Regul Oil
NDC 83021-740, Propylene Glycol, Panthenol, Thiamine HCL, lotion, from ANUBIS COSMETICS SL.
- Product NDC
- 83021-740
- Status
- Listed
- Labeler
- ANUBIS COSMETICS SL
- Dosage form
- LOTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- M006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83021-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALCOHOL52.5 mL/250mL
- NIACINAMIDE.025 g/250mL
- TIOXOLONE.25 g/250mL
- ARCTIUM LAPPA ROOT.0225 g/250mL
- RIBOFLAVIN.0025 g/250mL
- POLYOXYL 40 HYDROGENATED CASTOR OIL2 g/250mL
- METHYLPARABEN.5 g/250mL
- YEAST, UNSPECIFIED.14375 g/250mL
- FD&C YELLOW NO. 5.0015 g/250mL
- GLYCERIN.45 g/250mL
- FRAGRANCE 13576.5 g/250mL
- WATER179.89815 mL/250mL
- PANTHENOL.05 g/250mL
- LIMONENE, (+)-.10475 g/250mL
- ALLANTOIN.25 g/250mL
- CITRAL.00485 g/250mL
- PROPYLENE GLYCOL13 g/250mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83021-740-01 | 83021074001 | 250 mL in 1 BOTTLE, SPRAY (83021-740-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83021-740 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83021-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83021-740. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.